Gilead Sciences (GILD) News Today $83.94 +0.04 (+0.05%) (As of 09/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Frank Rimerman Advisors LLC Acquires 29,185 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Frank Rimerman Advisors LLC increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4,496.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,834 shares of the biopharmaceutical company'September 22 at 6:46 AM | marketbeat.com3 Dirt Cheap Stocks to Buy Right NowSeptember 21 at 7:36 AM | fool.comThrivent Financial for Lutherans Buys 1,262,193 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Thrivent Financial for Lutherans raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 140.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,159,356 shares of the biopharmaceutical comSeptember 21 at 7:00 AM | marketbeat.comGilead Sciences Unusual Options Activity For September 20September 21 at 5:15 AM | benzinga.comWall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend YieldsSeptember 20 at 9:00 AM | benzinga.comPacer Advisors Inc. Boosts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Pacer Advisors Inc. lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 24.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,889,663 shares of the biopharmaceutical company's stock after acqSeptember 20 at 8:05 AM | marketbeat.com55,000 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Resolute Capital Asset Partners LLCResolute Capital Asset Partners LLC bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 55,000 shares of tSeptember 19 at 7:54 AM | marketbeat.comGilead Sciences stock nears its all-time high: buy or sell?September 19 at 5:19 AM | msn.comAmalgamated Bank Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD)Amalgamated Bank lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 251,858 shares of the biopharmaceutical company's stockSeptember 18, 2024 | marketbeat.comGilead Sciences (NASDAQ:GILD) Stock Rating Reaffirmed by Cantor FitzgeraldSeptember 18, 2024 | americanbankingnews.comPrime Capital Investment Advisors LLC Sells 9,233 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Prime Capital Investment Advisors LLC cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 18.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 39,739 shares of the biopharmaSeptember 17, 2024 | marketbeat.comBuy Rating on Gilead Sciences: Underestimated Market Potential of Lenacapavir in HIV Treatment and PreventionSeptember 16, 2024 | markets.businessinsider.comJefferies Remains a Buy on Gilead Sciences (GILD)September 16, 2024 | markets.businessinsider.comGilead Sciences (NASDAQ:GILD) Earns "Neutral" Rating from Cantor FitzgeraldCantor Fitzgerald reiterated a "neutral" rating and set a $70.00 target price on shares of Gilead Sciences in a research report on Monday.September 16, 2024 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 17.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,057,598 shares of the biopharmaceutical company's stockSeptember 16, 2024 | marketbeat.comHold Rating on Gilead Sciences Amid Lenacapavir’s Promise and Market UncertaintiesSeptember 16, 2024 | markets.businessinsider.comGilead Sciences, Inc. (NASDAQ:GILD) Insider Johanna Mercier Sells 29,357 SharesSeptember 16, 2024 | americanbankingnews.comGilead Sciences, Inc. (NASDAQ:GILD) Stake Lifted by Oppenheimer Asset Management Inc.Oppenheimer Asset Management Inc. lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 20.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 183,224 shares of the biopharmaceutical company's stock after acquiring an additionaSeptember 15, 2024 | marketbeat.comShould You Be Worried About Gilead Sciences, Inc.'s (NASDAQ:GILD) 5.7% Return On Equity?September 14, 2024 | finance.yahoo.comGot $200? 2 Healthcare Stocks to Buy and Hold ForeverSeptember 14, 2024 | fool.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Prosperity Consulting Group LLCProsperity Consulting Group LLC lowered its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 31.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,370 shares of the biopharmaceutiSeptember 14, 2024 | marketbeat.comInsider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) Insider Sells 29,357 Shares of StockSeptember 14, 2024 | insidertrades.comInsider Sale: Johanna Mercier Sells 29,357 Shares of Gilead Sciences Inc (GILD)September 14, 2024 | finance.yahoo.comHBK Sorce Advisory LLC Has $2.98 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)HBK Sorce Advisory LLC lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 17.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 43,445 shares of the biopharSeptember 13, 2024 | marketbeat.comGilead: Lenacapavir Reduces HIV Infections By 96% In PURPOSE 2 TrialSeptember 13, 2024 | markets.businessinsider.comGilead posts second late-stage win for twice-yearly HIV therapySeptember 13, 2024 | msn.comBuy Rating Affirmed for Gilead Sciences on Lenacapavir’s Market-Changing Potential in PrEPSeptember 13, 2024 | markets.businessinsider.comGilead’s (NASDAQ:GILD) Latest Study Shows Further Progress Against HIVSeptember 13, 2024 | msn.comWhy Gilead Sciences Stock Thrashed the Market TodaySeptember 12, 2024 | fool.comGilead Sciences (NASDAQ:GILD) Shares Gap Up to $80.94Gilead Sciences (NASDAQ:GILD) Shares Gap Up to $80.94September 12, 2024 | marketbeat.comGilead's twice-yearly shot cut HIV infections by 96% in trialSeptember 12, 2024 | cnbc.comPrivate Wealth Partners LLC Has $1.65 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Private Wealth Partners LLC decreased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 66.2% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 24,094 shares of the biopharmaceutical company's stock after selling 47,September 12, 2024 | marketbeat.comGilead Sciences' (GILD) Overweight Rating Reaffirmed at Piper SandlerSeptember 12, 2024 | americanbankingnews.comGilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD)September 12, 2024 | americanbankingnews.comGilead Sciences (GILD) Stock Sinks As Market Gains: What You Should KnowSeptember 11, 2024 | msn.comAnalyst Holds Gilead Sciences Rating Amidst PURPOSE-2 Trial UncertaintiesSeptember 11, 2024 | markets.businessinsider.comGilead Sciences' (GILD) "Overweight" Rating Reiterated at Piper SandlerPiper Sandler reissued an "overweight" rating and set a $95.00 price objective on shares of Gilead Sciences in a research report on Wednesday.September 11, 2024 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Headlands Technologies LLCHeadlands Technologies LLC grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 74.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 24,049 shares of the biopharmaceutical company's stock after purchasing an addSeptember 11, 2024 | marketbeat.comStock Traders Buy High Volume of Gilead Sciences Call Options (NASDAQ:GILD)Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock investors bought 31,514 call options on the company. This is an increase of 50% compared to the average volume of 21,054 call options.September 10, 2024 | marketbeat.comGilead Sciences (NASDAQ:GILD) Stock, Guidance And ForecastSeptember 10, 2024 | benzinga.comJefferies Sticks to Its Buy Rating for Gilead Sciences (GILD)September 10, 2024 | markets.businessinsider.comGilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel TherapiesSeptember 10, 2024 | stockhouse.comGilead Sciences To Work With Genesis To Apply AI Platform To Discover, Advance TherapiesSeptember 10, 2024 | markets.businessinsider.comRPG Investment Advisory LLC Purchases 23,665 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)RPG Investment Advisory LLC increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 31.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 99,965 shares of the biopharmaceutical company's stock after buying an additionalSeptember 10, 2024 | marketbeat.comGilead Sciences' (GILD) "Neutral" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed a "neutral" rating and set a $70.00 price target on shares of Gilead Sciences in a research report on Monday.September 9, 2024 | marketbeat.comPrudential PLC Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Prudential PLC lowered its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 9.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 319,162 shares of the biopharmaceutical company'sSeptember 9, 2024 | marketbeat.comCaprock Group LLC Acquires 12,286 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Caprock Group LLC grew its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 44.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 40,177 shares of the biopharmaceutical company's stock after buying an additional 12,2September 9, 2024 | marketbeat.comLSV Asset Management Has $378.03 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)LSV Asset Management lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,509,889 shares of the biopharmaceutical company's stock afterSeptember 8, 2024 | marketbeat.comLetko Brosseau & Associates Inc. Has $66.38 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Letko Brosseau & Associates Inc. grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 967,533 shares ofSeptember 7, 2024 | marketbeat.comGilead Sciences, Inc. (GILD) Wells Fargo 2024 Healthcare Conference (Transcript)September 6, 2024 | seekingalpha.com Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼0.720.47▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼1817▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMGN News Today REGN News Today VRTX News Today ALNY News Today BIIB News Today MRNA News Today BMRN News Today UTHR News Today INCY News Today NBIX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredOur #1 Ticker for the Rare "Retirement Window"We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's mint...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Gilead Sciences, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GILD Stock Alerts